Combination therapies for previously untreated CLL

被引：1
|
作者：
Shanafelt, Tait D. [1 ]
Kay, Neil E. [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN 55905 USA
来源：
LANCET | 2007年 / 370卷 / 9583期
关键词：
D O I：
10.1016/S0140-6736(07)61100-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：197 / 198
页数：2
相关论文
共 50 条
  • [21] Targeted Therapies in CLL: Monotherapy Versus Combination Approaches
    Khan, Maliha
    Siddiqi, Tanya
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (06) : 525 - 533
  • [22] Targeted Therapies in CLL: Monotherapy Versus Combination Approaches
    Maliha Khan
    Tanya Siddiqi
    Current Hematologic Malignancy Reports, 2018, 13 : 525 - 533
  • [23] Chronic Lymphocytic Leukemia (CLL) Success with Combination Therapies
    Habel, Christoph
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (05) : 253 - 253
  • [24] A Phase 2 Study of Alemtuzumab-Ofatumumab (A plus O) Combination in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) - an Update
    Lundin, Jeanette
    Rosen, Steven T.
    Osterborg, Anders
    Frankfurt, Olga
    Winter, Jane N.
    Rademaker, Alfred
    Kreutzer, Jennifer
    Bacon, Elizabeth
    Sonnert-Husa, Sonja
    Ma, Shuo
    BLOOD, 2015, 126 (23)
  • [25] 2-CHLORODEOXYADENOSINE (CDA) FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    DELANNOY, A
    MARTIAT, P
    BOSLY, A
    FERRANT, A
    DENEYS, V
    MICHAUX, JL
    BLOOD, 1994, 84 (10) : A461 - A461
  • [26] Chemoimmunotherapy with ofatumumab in combination with CHOP in previously untreated follicular lymphoma
    Czuczman, Myron S.
    Hess, Georg
    Gadeberg, Ole V.
    Pedersen, Lars M.
    Goldstein, Nancy
    Gupta, Ira
    Jewell, Roxanne C.
    Lin, Thomas S.
    Lisby, Steen
    Strange, Claus
    Windfeld, Kristian
    Viardot, Andreas
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (04) : 438 - 445
  • [27] A phase II study of lenalidomide in previously untreated, symptomatic chronic lymphocytic leukemia (CLL)
    Chen, Christine I.
    Paul, Harminder
    Mariela, Pantoja
    Brandwein, Joseph
    Kukreti, Vishal
    Trudel, Suzanne
    Wei, Ellen
    Tong, Jieffei
    Moran, Mike
    BLOOD, 2007, 110 (11) : 608A - 608A
  • [28] FLUDARABINE IN UNTREATED AND PREVIOUSLY TREATED B-CLL PATIENTS - A REPORT ON EFFICIENCY AND TOXICITY
    SPRIANO, M
    CLAVIO, M
    CARRARA, P
    CANEPA, L
    MIGLINO, M
    PIERRI, I
    CELESTI, L
    ROSSI, E
    VIMERCATI, R
    BRUNI, R
    SANTINI, G
    GATTI, AM
    STURA, P
    GHIO, R
    PATRONE, F
    DAMASIO, E
    GOBBI, M
    HAEMATOLOGICA, 1994, 79 (03) : 218 - 224
  • [29] Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study
    Stilgenbauer, Stephan
    Leblond, Veronique
    Foa, Robin
    Boettcher, Sebastian
    Ilhan, Osman
    Knauf, Wolfgang
    Mikuskova, Eva
    Renner, Christoph
    Tausch, Eugen
    Woszczyk, Dariusz
    Gresko, Ekaterina
    Lundberg, Linda
    Moore, Tom
    Morris, Thea
    Robson, Susan
    Bosch, Francesc
    LEUKEMIA, 2018, 32 (08) : 1778 - 1786
  • [30] Oral fludarabine and cyclophosphamide in previously untreated CLL: Preliminary data on 59 pts.
    Cazin, B
    Maloum, K
    Divine, M
    Lepretre, S
    Travade, P
    Delmer, A
    Jaubert, J
    Lederlin, P
    Dreyfus, B
    Leporrier, M
    Harousseau, JL
    Grosbois, B
    Maloisel, F
    Eghbali, H
    Dumontet, C
    Benichou, J
    Guibon, O
    BLOOD, 2001, 98 (11) : 772A - 772A
12345